Ophthalmic Goods
Standard Industrial Classification: SIC 3851
Industry Insider Sentiment Analysis
The Ophthalmic Goods sector (SIC 3851) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 03:07 | 2023-12-14 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Director, Officer | SELL | $39.70 | 40,000 | $1,588,184 | 889,610 |
| 2023-12-15 03:15 | 2023-12-14 | COO | COOPER COMPANIES, INC. | PETERSMEYER GARY S | Director | SELL | $368.55 | 300 | $110,565 | 2,464 |
| 2023-12-13 01:32 | 2023-12-08 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Director, Officer | OPT+S | $10.56 | 56,038 | $591,761 | 106 |
| 2023-12-13 01:31 | 2023-12-08 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Director, Officer | OPT+S | $10.56 | 56,038 | $591,761 | 235 |
| 2023-12-13 01:30 | 2023-12-08 | WRBY | Warby Parker Inc. | Miller Steven Clive | Officer | OPT+S | $11.19 | 29,310 | $328,046 | 177,754 |
| 2023-12-13 02:49 | 2023-12-08 | RXST | RxSight, Inc. | Warner Robert Keith | Director | SELL | $35.03 | 20,000 | $700,552 | 23,750 |
| 2023-12-07 00:11 | 2023-12-06 | STAA | STAAR SURGICAL CO | Zhou Lilian Yansheng | Director | BUY | $30.74 | 850 | $26,129 | 2,327 |
| 2023-12-01 03:08 | 2023-11-28 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $31.50 | 434,991 | $13,703,826 | 10,537,835 |
| 2023-12-01 03:32 | 2023-11-28 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Director | SELL | $29.73 | 494,313 | $14,695,678 | 0 |
| 2023-11-17 03:31 | 2023-11-14 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Director | SELL | $27.18 | 500,000 | $13,590,750 | 494,313 |
| 2023-11-15 03:13 | 2023-11-10 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $32.74 | 34,827 | $1,140,131 | 10,102,844 |
| 2023-11-10 03:01 | 2023-11-07 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $33.42 | 289,140 | $9,662,770 | 10,068,017 |
| 2023-11-07 03:01 | 2023-11-02 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $34.93 | 309,154 | $10,797,513 | 9,778,877 |
| 2023-10-07 02:43 | 2023-10-04 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $37.81 | 205,296 | $7,762,468 | 9,469,723 |
| 2023-09-23 02:18 | 2023-09-21 | STAA | STAAR SURGICAL CO | Lin Elizabeth Yeu | Director | BUY | $40.00 | 2,500 | $100,000 | 2,855 |
| 2023-09-22 03:31 | 2023-09-19 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $40.12 | 291,383 | $11,689,354 | 9,264,427 |
| 2023-09-13 01:05 | 2023-09-08 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Director, Officer | OPT+S | $11.92 | 5,016 | $59,791 | 106 |
| 2023-09-13 01:02 | 2023-09-08 | WRBY | Warby Parker Inc. | Miller Steven Clive | Officer | OPT+S | $11.92 | 7,607 | $90,675 | 187,252 |
| 2023-09-13 01:00 | 2023-09-08 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Director, Officer | OPT+S | $11.92 | 5,016 | $59,791 | 235 |
| 2023-09-12 01:15 | 2023-09-07 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Director | SELL | $30.14 | 32,950 | $992,968 | 20,223 |
| 2023-09-08 02:00 | 2023-09-05 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | BUY | $41.42 | 189,962 | $7,868,910 | 8,973,044 |
| 2023-08-30 00:10 | 2023-08-29 | RXST | RxSight, Inc. | Maniar Shweta | Director | SELL | $28.06 | 4,292 | $120,451 | 24,947 |
| 2023-08-29 02:44 | 2023-08-25 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Director | SELL | $29.25 | 16,208 | $474,129 | 53,173 |
| 2023-08-24 00:00 | 2023-08-21 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $12.23 | 402,535 | $4,923,003 | 9,690,563 |
| 2023-08-18 23:08 | 2023-08-17 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Director | SELL | $29.62 | 33,135 | $981,571 | 68,411 |
| 2023-08-17 00:12 | 2023-08-14 | WRBY | Warby Parker Inc. | Briggs Teresa | Director | SELL | $12.94 | 9,720 | $125,788 | 13,820 |
| 2023-08-07 23:16 | 2023-08-07 | STAA | STAAR SURGICAL CO | WEISNER AIMEE S | Director | BUY | $48.72 | 2,000 | $97,440 | 5,417 |
| 2023-06-27 00:00 | 2023-06-22 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $11.91 | 24,151 | $287,638 | 10,093,098 |
| 2023-06-23 00:00 | 2023-06-20 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $11.91 | 220,610 | $2,627,112 | 10,117,249 |
| 2023-06-21 00:00 | 2023-06-15 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $11.94 | 88,237 | $1,053,382 | 10,337,859 |
| 2023-06-16 00:00 | 2023-06-13 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $12.03 | 175,364 | $2,109,243 | 10,426,096 |
| 2023-06-13 00:39 | 2023-06-08 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $12.02 | 57,028 | $685,260 | 10,601,460 |
| 2023-06-13 00:36 | 2023-06-09 | WRBY | Warby Parker Inc. | Miller Steven Clive | Officer | OPT+S | $11.69 | 7,652 | $89,452 | 176,377 |
| 2023-06-13 00:35 | 2023-06-09 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Director, Officer | OPT+S | $11.69 | 5,043 | $58,953 | 235 |
| 2023-06-13 00:35 | 2023-06-09 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Director, Officer | OPT+S | $11.69 | 5,043 | $58,953 | 106 |
| 2023-06-09 00:36 | 2023-06-06 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $12.11 | 377,421 | $4,572,380 | 10,658,488 |
| 2023-05-24 23:42 | 2023-05-22 | EYE | National Vision Holdings, Inc. | PEELER D RANDOLPH | Director | BUY | $25.65 | 40,470 | $1,038,092 | 148,880 |
| 2023-05-19 23:30 | 2023-05-17 | EYE | National Vision Holdings, Inc. | TAYLOR THOMAS V | Director | BUY | $24.04 | 2,079 | $49,979 | 25,556 |
| 2023-05-17 19:22 | 2023-05-15 | EYE | National Vision Holdings, Inc. | FAHS L READE | Director, Officer | BUY | $23.81 | 12,625 | $300,601 | 556,550 |
| 2023-04-04 01:32 | 2023-03-31 | COO | COOPER COMPANIES, INC. | Ricupati Agostino | Officer | SELL | $370.00 | 1,000 | $370,000 | 863 |
| 2023-03-18 01:04 | 2023-03-17 | STAA | STAAR SURGICAL CO | Holliday Keith | Officer | SELL | $61.97 | 823 | $51,001 | 27,633 |
| 2023-03-15 23:18 | 2023-03-15 | COO | COOPER COMPANIES, INC. | PETERSMEYER GARY S | Director | SELL | $335.78 | 700 | $235,044 | 2,134 |
| 2023-03-14 23:34 | 2023-03-10 | WRBY | Warby Parker Inc. | Miller Steven Clive | Officer | OPT+S | $10.95 | 14,251 | $156,058 | 165,547 |
| 2023-03-14 23:33 | 2023-03-10 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Director, Officer | OPT+S | $11.04 | 6,517 | $71,948 | 235 |
| 2023-03-14 23:33 | 2023-03-10 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Director, Officer | OPT+S | $11.04 | 6,517 | $71,948 | 106 |
| 2023-03-10 02:03 | 2023-03-09 | COO | COOPER COMPANIES, INC. | Warner Gerard H III | Officer | SELL | $340.53 | 1,216 | $414,087 | 1,290 |
| 2023-03-10 00:30 | 2023-03-07 | WRBY | Warby Parker Inc. | Briggs Teresa | Director | SELL | $12.05 | 18,900 | $227,800 | 19,246 |
| 2023-03-08 03:42 | 2023-03-07 | COO | COOPER COMPANIES, INC. | WEISS ROBERT S | Director | OPT+S | $337.72 | 37,510 | $12,667,881 | 70,000 |
| 2023-02-14 02:20 | 2023-02-10 | RXST | RxSight, Inc. | Tammenoms Bakker Juliet | Director | BUY | $12.50 | 480,000 | $6,000,000 | 980,000 |
| 2023-02-07 01:18 | 2023-02-02 | WRBY | Warby Parker Inc. | Durable Capital Partners LP | 10% owner | SELL | $17.27 | 575,894 | $9,944,192 | 11,035,909 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Ophthalmic Goods sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3851) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Ophthalmic Goods
Every transaction in the Ophthalmic Goods industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.